Plasma cystatin C was also indicated to modulate the clinical expression of cognitive decline; a significant anticipation of the conversion to dementia was observed in MCI subjects, when the detected plasma cystatin C levels were below 1,067 ng/ml (Ghidoni et al., 2010). This evidence concerns the gene CST3 and Mental deterioration.